Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest drug half life time in humans after IV administration.
Constraint: You must select all options from a, b, or c without using any other words.
Options:
[a] CCCCCCCCC/C=C/C=C/C(=O)CCC(=O)NC1[C@H](C(O)CO)O[C@H](Nc2ncnc3nc[nH]c23)[C@H](O)[C@@H]1O
[b] O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl
[c] C=CC[N+]12CC[C@@]34c5ccccc5N5/C=C6/[C@H]7C[C@H]8[C@@]9(CC[N@@+]8(CC=C)C/C7=C/CO)c7ccccc7N(/C=C(/[C@@H](C[C@@H]31)/C(=C\CO)C2)[C@H]54)[C@@H]69
Answer: a
Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest {half_life_duration__names__noun}.
Constraint: You must select all options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%half_life_duration%}
Answer: {%multiple_choice_result}
(5E,7E)-N-[(2R,4R,5R,6S)-2-(1,2-dihydroxyethyl)-4,5-dihydroxy-6-(7H-purin-6-ylamino)oxan-3-yl]-4-oxoheptadeca-5,7-dienamide